Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,099 public trials 1,778 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, not recruiting

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

NCT03887455

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • Banner Alzheimer's Institute- Clinical Trials Department Phoenix, Arizona, United States
  • Banner Sun Health Research Sun City, Arizona, United States
  • Neurological Associates of Tucson dba Center for Neurosciences Tucson, Arizona, United States
  • Neurology Center of North Orange County Fullerton, California, United States
View all 247 locations
View Trial Details
Active, not recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, not recruiting

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

NCT06392009

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Focal Cortical Dysplasia, +14 more
Locations
  • Queensland Children Hospital South Brisbane, Australia
  • University Hospitals Leuven, Pediatric Neurology Leuven, Belgium
  • Alberta Children's Hospital Calgary, Canada
  • The Hospital for Sick Children (Sick Kids) Toronto, Canada
View all 18 locations
View Trial Details
Active, not recruiting

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

NCT04685590

Conditions
Alzheimer Disease, Alzheimer Disease, Early Onset, Brain Diseases, +10 more
Locations
  • Wake Forest Health Sciences Winston-Salem, North Carolina, United States
  • Fundación ACE Clinical Site Barcelona, Spain
  • Hospital Clínic de Barcelona Site Barcelona, Spain
  • Sant Pau Clinical Site Barcelona, Spain
View Trial Details

Related conditions